23andMe-A (ME)
$0.50
0.11 (21.84%)
ME Stock Quote Delayed 30 Minutes
ME Stock Earnings: 23andMe Holding Beats EPS, Misses Revenue for Q1 2025
ME stock results show that 23andMe Holding beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$0.77
Market Cap
20.66M
PE Ratio
-0.50
EPS
-0.9943
Volume (Avg. Vol.)
29.17M
Day's Range
$0.60 - $1.10
52-Week Range
$0.53 - $12.76
Dividend & Yield
N/A (N/A)
ME Stock Predictions, Articles, and 23andMe-A News
ME Stock Earnings: 23andMe Holding Beats EPS, Beats Revenue for Q4 2024
ME stock results show that 23andMe Holding beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal
23andMe stock is rallying on Wednesday after the company's CEO announced plans to take ME shares private in a potential deal.
3 Gene Testing Stocks to Buy Before They Take Off
The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.
CFO Transition Rocks 23andMe (ME) Stock
23andMe's CFO, Steven Schoch, is stepping down. But ME stock's fall today likely has more to do with broader market forces.
What Is Going on With 23andMe (ME) Stock Today?
23andMe, Invitae and others are seeing an explosive rally, but investors want to know if ME stock and others can continue to climb.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! It's time for another dive into the biggest pre-market stock movers as we check out what's happening Thursday morning!
ME Stock: 6 Things to Know About 23andMe as Shares Shoot Higher Today
23andMe (ME) stock is running higher on Friday as investors pile on with heavy trading thanks to a recent interview on CNBC.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning! It's the final day of the week and we're starting the end with a look at the biggest pre-market stock movers for Friday!
ME Stock: The Credit Suisse Call Giving 23andMe a Boost Today
23andMe (ME) stock is rising higher on Tuesday after Credit Suisse weighed in on the personal genomics and biotechnology company.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! We're taking a look at the biggest pre-market stock movers for Wednesday and that includes the winners and losers.
ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut
23andMe (ME) stock is on the move Friday after the genetics company made its public debut on the Nasdaq Exchange yesterday.
VGAC Stock: Everything You Need to Know About Richard Branson, 23andMe and This Week’s SPAC Merger
Businessman Richard Branson and 23andMe are making headlines after Branson's Virgin Acquisition Group will complete its merger this week.
VG Acquisition Stock: The Value’s in the DNA Vault, Not the Spit Kits
If 23andme is worth $3.5 billion, it's based on the long-term asset of its DNA database, not the cash it gets from consumers for its saliva testing kits.
